# Sanofi Pasteur, TIV + H1N1, Pediatric Population

> **NCT00943202** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 531 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated H1N1 Vaccine
- **BIOLOGICAL:** Trivalent Inactivated Influenza Vaccine

## Key facts

- **NCT ID:** NCT00943202
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 531 (ACTUAL)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943202, "Sanofi Pasteur, TIV + H1N1, Pediatric Population". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00943202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*